Literature DB >> 9182921

Expansion of unusual CD4+ T cells in severe rheumatoid arthritis.

P B Martens1, J J Goronzy, D Schaid, C M Weyand.   

Abstract

OBJECTIVE: The repertoire of T cells in patients with rheumatoid arthritis (RA) is characterized by clonal expansion of selected CD4+ T cells, which are autoreactive and lack the expression of the functionally important CD28 molecule. The goal of this study was to determine the contribution of these unusual lymphocytes to the disease process.
METHODS: RA patients (n = 108) and normal controls (n = 53) were examined for the expression of CD4+ CD28- T cells by 2-color fluorescence-activated cell sorter analysis. Clinical data were ascertained by retrospective chart review.
RESULTS: The frequencies of CD4+ CD28- T cells displayed a bimodal distribution, defining carriers and noncarriers in normal subjects and RA patients. In longitudinal studies, the noncarrier and carrier phenotypes were stable over time. Carriers of CD4+ CD28- T cells accumulated in the RA population (64% versus 45%; P = 0.02). The expansion of CD4+ CD28- T cells correlated with extraarticular involvement, but not with disease duration, antirheumatic treatment, or severity of joint destruction. The patient subsets with nodular disease (P = 0.02) and rheumatoid organ disease (P = 0.04) had the highest proportion of CD4+ CD28- T cell carriers. The size of the CD4+ CD28- compartment correlated with extraarticular progression of RA (P = 0.001 in nodular RA, P = 0.003 in rheumatoid organ disease).
CONCLUSION: The bimodality of distribution of CD4+ CD28- T cell frequencies is compatible with genetic control of the generation of these unusual T cells. In RA patients, CD4+ CD28- T cells are not an epiphenomenon of the disease process, but predispose patients to developing inflammatory lesions in extraarticular tissues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182921     DOI: 10.1002/art.1780400615

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  97 in total

1.  CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells.

Authors:  Andrew P Fontenot; Laia Gharavi; Sean R Bennett; Scott J Canavera; Lee S Newman; Brian L Kotzin
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

2.  Active Crohn's disease patients show a distinctive expansion of circulating memory CD4+CD45RO+CD28null T cells.

Authors:  Jaime García de Tena; Luis Manzano; Juan Carlos Leal; Esther San Antonio; Verónica Sualdea; Melchor Alvarez-Mon
Journal:  J Clin Immunol       Date:  2004-03       Impact factor: 8.317

3.  [How do T-cells become activated in joints?].

Authors:  M Pierer; U Wagner
Journal:  Z Rheumatol       Date:  2010-10       Impact factor: 1.372

Review 4.  The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR.

Authors:  Jeroen van Bergen; Frits Koning
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

Review 5.  Rheumatoid Vasculitis: A Diminishing Yet Devastating Menace.

Authors:  Shweta Kishore; Lisa Maher; Vikas Majithia
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

6.  Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis.

Authors:  B Berner; G Wolf; K M Hummel; G A Müller; M A Reuss-Borst
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

7.  Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis.

Authors:  C Duftner; C Dejaco; W Kullich; A Klauser; C Goldberger; A Falkenbach; M Schirmer
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

8.  Use of immune modulation by human adipose-derived mesenchymal stem cells to treat experimental arthritis in mice.

Authors:  Li Zhang; Xiao-Yan Wang; Peng-Jun Zhou; Zhe He; Hai-Zhao Yan; Dan-Dan Xu; Ying Wang; Wu-Yu Fu; Bi-Bo Ruan; Sheng Wang; Hai-Xuan Chen; Qiu-Ying Liu; Yu-Xia Zhang; Zhong Liu; Yi-Fei Wang
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

Review 9.  Rheumatoid arthritis and cardiovascular disease.

Authors:  Cynthia S Crowson; Katherine P Liao; John M Davis; Daniel H Solomon; Eric L Matteson; Keith L Knutson; Mark A Hlatky; Sherine E Gabriel
Journal:  Am Heart J       Date:  2013-08-29       Impact factor: 4.749

10.  Perturbation of the T cell repertoire in rheumatoid arthritis.

Authors:  U G Wagner; K Koetz; C M Weyand; J J Goronzy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.